ZYTIGA for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where ZYTIGA was used for Neoplasm malignant.
Most Reported Side Effects for ZYTIGA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 73 | 16.9% | 73 | 8 |
| Disease progression | 31 | 7.2% | 23 | 4 |
| Prostatic specific antigen increased | 27 | 6.3% | 8 | 6 |
| Blood alkaline phosphatase increased | 19 | 4.4% | 12 | 2 |
| Drug ineffective | 19 | 4.4% | 3 | 2 |
| Asthenia | 17 | 3.9% | 4 | 9 |
| Fatigue | 17 | 3.9% | 3 | 8 |
| Anaemia | 15 | 3.5% | 2 | 10 |
| Haemoglobin decreased | 12 | 2.8% | 11 | 0 |
| Pain | 12 | 2.8% | 3 | 7 |
| Prostate cancer | 12 | 2.8% | 9 | 4 |
| Urinary tract infection | 12 | 2.8% | 3 | 7 |
| Atrial fibrillation | 11 | 2.6% | 3 | 6 |
| Hypokalaemia | 11 | 2.6% | 3 | 8 |
| Pneumonia | 11 | 2.6% | 3 | 9 |
Other Indications for ZYTIGA
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)